APA (7th ed.) Citation

SS, P., RS, C., JH, L., FK, C., EN, H., F, Y., . . . CL, D. (2025). Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi Nanomedicine. Cancer research communications, 5(3), 458. https://doi.org/10.1158/2767-9764.CRC-24-0261

Chicago Style (17th ed.) Citation

SS, Patel, et al. "Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using MTORC2-Directed RNAi Nanomedicine." Cancer Research Communications 5, no. 3 (2025): 458. https://doi.org/10.1158/2767-9764.CRC-24-0261.

MLA (9th ed.) Citation

SS, Patel, et al. "Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using MTORC2-Directed RNAi Nanomedicine." Cancer Research Communications, vol. 5, no. 3, 2025, p. 458, https://doi.org/10.1158/2767-9764.CRC-24-0261.